ID   Mel Cher 5C
AC   CVCL_B6K9
SY   mel Cher 5; Cher 5C
DR   cancercelllines; CVCL_B6K9
DR   Wikidata; Q112129264
RX   DOI=10.17650/1726-9784-2016-15-3-90-94;
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6K8 ! Mel Cher
SX   Male
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   DOI=10.17650/1726-9784-2016-15-3-90-94;
RA   Morozova L.F., Suraeva N.M., Burova O.S., Barmashov A.E.,
RA   Baryshnikova M.A.;
RT   "Changes in the morphological and immunological characteristics of
RT   Mel Cher melanoma cells in response to low concentration of embryo
RT   calf serum.";
RL   Ross. Bioterap. Zh. 15:90-94(2016).
//